Search Results - "Allen, Karen O"
-
1
Safety and Immunogenicity of a DNA Vaccine Encoding Carcinoembryonic Antigen and Hepatitis B Surface Antigen in Colorectal Carcinoma Patients
Published in Clinical cancer research (01-09-2002)“…Despite an abundance of preclinical data, relatively little is known regarding the efficacy of DNA vaccination in humans. Here, we present results from a…”
Get full text
Journal Article -
2
Phase I Study of the Intratumoral Administration of Recombinant Canarypox Viruses Expressing B7.1 and Interleukin 12 in Patients with Metastatic Melanoma
Published in Clinical cancer research (01-06-2005)“…The objective of this study was to evaluate the safety and activity of the intratumoral administration of the immune costimulatory molecule, B7.1, encoded by a…”
Get full text
Journal Article -
3
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor
Published in Vaccine (26-01-2004)“…KSA (Ep-CAM) is highly expressed by colorectal cancers. The safety and immunologic effects of a vaccine consisting of recombinant baculovirus-derived KSA…”
Get full text
Journal Article -
4
Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse
Published in Journal of immunotherapy (1997) (01-07-2005)“…Immunization with plasmid DNA represents an attractive method for increasing cellular immune responses against cancer antigens. The safety and immunologic…”
Get full text
Journal Article -
5
Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma
Published in Human gene therapy (01-01-2005)“…The aim of this study was to evaluate the tolerability and activity of intratumoral administered human interleukin 12 encoded by a vector derived from the…”
Get more information
Journal Article -
6
Human Autoantibodies to Carcinoembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine
Published in Clinical cancer research (01-01-2000)“…Carcinoembryonic antigen (CEA) is a well-characterized oncofetal glycoprotein whose overexpression by human adenocarcinomas has been a target for cancer…”
Get full text
Journal Article -
7
Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration
Published in Clinical cancer research (01-09-1999)“…The principal objectives of this trial were twofold: ( a ) to examine the safety and relative efficacy of intradermal needle injection versus s.c. jet…”
Get full text
Journal Article -
8
Antitumor activity of the intratumoral injection of fowlpox vectors expressing a triad of costimulatory molecules and granulocyte/macrophage colony stimulating factor in mesothelioma
Published in International journal of cancer (20-01-2005)“…Deficiency in costimulatory molecule expression has been implicated in the ability of tumors to escape immune effectors. The activity of the intratumoral…”
Get full text
Journal Article -
9
Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer
Published in The Prostate (01-12-2005)“…BACKGROUND Gonadotropin releasing hormone (GnRH)‐DT vaccine elicits antibody that may inhibit prostate cancers indirectly by blocking GnRH induced gonadotropin…”
Get full text
Journal Article -
10
Quality assurance for investigator-initiated trials
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
11
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen
Published in Clinical cancer research (01-11-1998)“…In preparation for a Phase I trial of DNA immunization against carcinoembryonic antigen (CEA) in patients with colorectal carcinoma, we have produced a single…”
Get full text
Journal Article -
12
Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells
Published in Immunopharmacology (01-07-1998)“…The antiproliferative effect of BCX-34 was tested in normal human peripheral blood mononuclear cells (PBMCs) induced to proliferate with OKT3, tetanus toxoid,…”
Get full text
Journal Article